We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Certain Combo Products Can Qualify for User Fee Waiver
Certain Combo Products Can Qualify for User Fee Waiver
December 14, 2005
Combination product manufacturers can cut their application user fees by as much as 50 percent if their products qualify for the "barrier to innovation" waiver established by the Prescription Drug User Fee Act (PDUFA), according to a recent FDA guidance.